Areas of Focus
- Major respiratory infections and lung injury
- Immune mechanisms of new/emerging infectious diseases, development and evaluation of immunoprophylaxis technologies
- T-cell immunity in acute infections and tumors
Publications
- Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial., Co-corresponding author, 2023
- SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants., Corresponding author, 2022
- SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies., First author, 2022
- Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection., First author, 2021
- Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease., First author, 2018
Awards
- National High-Level Talent Special Support Plan (2023): Detail
- Pearl River Scholar Distinguished Professor (2019): Detail
- Guangzhou High-Level Talent (Outstanding Expert) (2019): Detail
- Ministry of Human Resources and Social Security High-Level Overseas Talent (2020): Detail